Newsroom
Press releases
- 13/04/2026
DETECT Abstracts Selected for Oral Presentation at European Endometriosis Congress 2026
Serac Healthcare Limited announces that two abstracts on the “Detecting Endometriosis expressed inTegrins using teChneTium-99m” imaging (DETECT) study, have been selected for oral presentation in the “Best Submitted Abstracts” sessions at the 8th European Endometriosis Congress taking place from 23rd to 25th April in Bologna, Italy.
- 12/02/2026
⁹⁹ᵐTc-maraciclatide Granted FDA Fast Track Designation for the Visualization of Inflammation in Interstitial Lung Disease
Serac Healthcare Limited announced today that the US Food and Drug Administration (FDA) has granted Fast Track Designation to 99mTc-maraciclatide as a diagnostic SPECT-CT agent for the “visualization of inflammation in the lungs of patients with known and suspected interstitial lung disease (ILD).”
- 22/10/2025
Publication of Clinical Results: ⁹⁹ᵐTc-maraciclatide Demonstrates Excellent Potential as a Whole-Body Imaging Method for Rheumatoid Arthritis
Serac Healthcare announces that the findings from a Phase II study evaluating a novel molecular imaging agent, 99mTc-maraciclatide, as an imaging marker for rheumatoid arthritis (RA) have been published online in Academic Radiology.
- 09/10/2025
Chapter on 99mTc-maraciclatide Published in the 2025 EANM Technologists’ Guide
Serac Healthcare highlights that a chapter on 99mTc-maraciclatide as an imaging agent for diagnosing endometriosis was published in the European Association of Nuclear Medicine’s Technologists' Guide 2025, which launched at EANM’s annual congress this week.
- 29/09/2025
Molecular Imaging of Interstitial Lung Disease with Maraciclatide: PREDICT-ILD Data Presented at ERS
Serac Healthcare and the University of Exeter, today announce the first findings from a study evaluating a novel molecular imaging agent, 99mTc-maraciclatide, as an imaging marker for interstitial lung disease evaluation. The data will be presented at the European Respiratory Society conference taking place from 27 September to 1 October in Amsterdam.
- 18/06/2025
Professor Alan Perkins Awarded MBE for Services to Patient Care and Clinical Science
Serac Life Sciences, the parent company of molecular imaging businesses Serac Healthcare Ltd and Serac Imaging Systems Ltd, announce that their Scientific Advisor, Professor Alan Perkins, has been awarded a Member of the Order of the British Empire (MBE) in the King’s Birthday Honours in recognition of his outstanding services to patient care and clinical science.
Events
We will be represented at the following conferences:
